Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowNet Cash FlowOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RAPT Therapeutics (RAPT) Other Working Capital Changes: 2019-2024

Historic Other Working Capital Changes for Therapeutics (RAPT) over the last 6 years, with Dec 2024 value amounting to -$2.9 million.

  • Therapeutics' Other Working Capital Changes fell 3.45% to -$720,000 in Q4 2024 from the same period last year, while for Dec 2024 it was -$2.9 million, marking a year-over-year decrease of 5.47%. This contributed to the annual value of -$2.9 million for FY2024, which is 5.47% down from last year.
  • Latest data reveals that Therapeutics reported Other Working Capital Changes of -$2.9 million as of FY2024, which was down 5.47% from -$2.7 million recorded in FY2023.
  • Therapeutics' Other Working Capital Changes' 5-year high stood at $965,000 during FY2020, with a 5-year trough of -$3.4 million in FY2021.
  • In the last 3 years, Therapeutics' Other Working Capital Changes had a median value of -$2.7 million in 2023 and averaged -$2.6 million.
  • In the last 5 years, Therapeutics' Other Working Capital Changes slumped by 455.65% in 2021 and then skyrocketed by 38.90% in 2022.
  • Yearly analysis of 5 years shows Therapeutics' Other Working Capital Changes stood at $965,000 in 2020, then crashed by 455.65% to -$3.4 million in 2021, then spiked by 38.90% to -$2.1 million in 2022, then fell by 29.09% to -$2.7 million in 2023, then dropped by 5.47% to -$2.9 million in 2024.